ClearBridge Investments
BHVN

ClearBridge Investments’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

ClearBridge Investments’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-830,668
Closed -$126M – 769
2022
Q3 		$126M Sell
830,668
-108
-0% -$16K 0.13% 163
2022
Q2 		$121M Sell
830,776
-321,053
-28% -$41M 0.11% 176
2022
Q1 		$137M Buy
1,151,829
+279,259
+32% +$34.8M 0.1% 192
2021
Q4 		$120M Buy
872,570
+794
+0.1% +$101K 0.08% 222
2021
Q3 		$121M Sell
871,776
-2,538
-0.3% -$317K 0.09% 207
2021
Q2 		$84.9M Buy
874,314
+116,974
+15% +$9.49M 0.06% 265
2021
Q1 		$51.8M Buy
757,340
+223,709
+42% +$18.1M 0.04% 341
2020
Q4 		$45.7M Buy
533,631
+164,475
+45% +$13.9M 0.04% 343
2020
Q3 		$24M Buy
369,156
+89,811
+32% +$5.89M 0.02% 395
2020
Q2 		$20.4M Buy
+279,345
New +$14.9M 0.02% 408

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

ClearBridge Investments's BHVN Position: Q4 2022 in Review

ClearBridge Investments sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 830,668 shares — an estimated $126M sold.

ClearBridge Investments first reported a position in BHVN in Q2 2020 and held it in 10 quarters. The position peaked at $137M in Q1 2022. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • ClearBridge Investments reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • ClearBridge Investments sold 830,668 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $126M.
  • ClearBridge Investments first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2020 and held it in 10 quarters.
  • ClearBridge Investments's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $137M in Q1 2022.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on ClearBridge Investments's 13F filing for Q4 2022, filed 10 Feb 2023.